The aims of this study were to isolate sesquiterpene compounds from the largehead atractylodes rhizome (LAR) and to investigate their effects on B16 cancer cells. A total of 8 sesquiterpenes from LAR were identified, of which eudesm-4 (15), 7-diene-9a, 11-diol (7) was isolated for the first time. All 8 compounds inhibited growth of B16 cells, and atractylenolide I (AT-I), atractylenolide II (AT-II), and atractylenolactam (ATR) were the most potent, with IC 50 values of 76.46, 84.02, and 54.88 mΜ, respectively. Monomer lactone or lactam structures in the 8 compounds appeared to be critical for their antiproliferative activities. In addition, AT-I, AT-II, and ATR could induce cell differentiation and inhibit cell migration. Western blot analysis indicated that 2 of the compounds, AT-I and AT-II, could inactivate ERK, where all 3 inhibited AKT activation, suggesting that Ras/ERK and PI3K/AKT signaling pathways are involved in the action mechanisms of the LAR sesquiterpene compounds.
Introduction
Largehead atractylodes rhizome (LAR), the dried rhizome of Atractylodes macrocephala Koidz (Bai Zhu in Chinese), is a traditional Chinese medicinal herb. According to the theory of traditional Chinese medicine, LAR can invigorate the function of the Spleen and replenish qi. 1 Phytochemical studies have shown that LAR is rich in sesquiterpene compounds. [2] [3] [4] Bioassays demonstrated that extracts/ sesquiterpene compounds from LAR have various pharmacological activities, such as anti-inflammatory, 3, 5, 6 antiulcer, [7] [8] [9] anti-lipid-peroxidation 10 and antitumor [11] [12] [13] activities. Apoptosis induction 14, 15 and antiangiogenesis 16 have been implicated in the anticancer properties of one of the LAR sesquiterpenes-namely, atractylenolide І (AT-I).
Clinical studies have shown that AT-І can reduce the symptoms of patients with gastric cancer cachexia by modulating cytokine production and inhibiting the proteolysis of a proteolysis-inducing factor. 17, 18 Although sesquiterpene compounds from LAR have been extensively investigated for their anticancer activities in diverse carcinoma cell lines, their effects on melanoma cells have not been reported.
Malignant melanoma is one of the most aggressive forms of skin cancer with high metastatic potential and extraordinary resistance to cytotoxic agents. 19 Despite extensive research and partial successes gained by the use of nitrosoureas, taxanes, and cytokines, 20, 21 currently, there is no effective chemotherapy against invasive melanoma. Therefore, development of new drugs against malignant melanoma is imperative.
In the present study, we isolated sesquiterpene compounds from LAR and examined their anticancer properties with regard to B16 melanoma cells. Preliminary investigations were made into the biochemical mechanisms by which the LAR sesquiterpenes exert these effects. 
Materials and Methods

Herbal Material
Extraction and Isolation
Powdered LAR (16.0 kg) was soaked in 95% ethanol at room temperature for 3 days, and the extract was evaporated under reduced pressure to yield 2 kg crude extract. The crude extract was dissolved in methanol and suspended in 2 times its weight of diatomite and then partitioned with ethyl acetate and methanol, yielding ethyl acetate extract (600 g) and methanol extract (800 g) after removal of solvents. The ethyl acetate extract was subjected to column chromatography over silica gel and eluted with petroleum ether, followed by petroleum ether-acetic ether (2:1), petroleum ether-acetic ether (1:1), and acetic ether sequentially to give 4 fractions (A1-A4). Fraction A1 was subjected to column chromatography over silica gel eluting with acetic ether-petroleum ether by increasing the polarity to yield atractylenolide II (AT-II; 500 mg), junipercomphor (JUN; 200 mg), biatractylenolide (BIA; 20 mg), and biepiasterolide (BIE; 20 mg). Repeated silica gel column chromatography of fractions A2-A4 yielded the following compounds: AT-І (500 mg), AT-III (1 g), atractylenolactam (ATR; 16 mg), and eudesm-4 (15), 7-diene-9a, 11-diol (7) (EUD; 20 mg).
Bioassay Sample Preparation
Stock solution (100 mM) of each isolated compound from LAR was prepared in dimethyl sulfoxide (DMSO; Sigma, France). Aliquots were stored at -20°C. Immediately prior to use, each stock solution was diluted using culture medium to various concentrations.
Cell Culture
Murine melanoma B16 cells (Shanghai Institutes for Biological Science, Chinese Academy of Sciences, China) grown in RPMI 1640 medium (GIBICO, USA) supplemented with 10% fetal bovine serum (GIBICO, USA) and 1% penicillin/streptomycin (GIBCO, USA) were cultured at 37°C in a humidified atmosphere of 5% CO 2 .
Cell Viability Assay
Cell viability was determined using MTT (methyl thiazolyl tetrazolium bromide, Sigma, USA) assay. 22 Briefly, B16 cells were seeded in 96-well plates (5 × 10 3 cells/ well) and allowed to adhere at 37°C for 12 hours. Test samples were then added to individual wells. Control cells were treated with 0.2% DMSO. After 72 hours of incubation, 10 mL of MTT solution (5 mg/mL in phosphate buffered saline [PBS]) was added to each well, and cells were incubated at 37°C for 4 hours. Then, 50 mL of stop solution (10% SDS [sodium dodecyl sulfate]-5% n-butanol-0.01M HCl) was added to dissolve the crystal in each well. Following 12 hours of incubation, optical densities were determined at 570 nm and 630 nm with a microplate spectrophotometer (BD Bioscience, USA). Each treatment was performed in triplicate, and each experiment was repeated at least 3 times.
Cell Differentiation Assay
Cells were treated with 100 mM AT-І, AT-II, or ATR. After 72 hours of incubation, morphological changes were observed under a microscope (Olympus, Japan). Differentiation and mature phenotype were characterized by the formation of dendritelike cellular protrusions. 16, 23 Tyrosinase Activity Assay Cellular tyrosinase activity was measured as previously described with a slight modification. 24 Briefly, B16 cells were seeded in 6-well plates (20 × 10 4 cells/well) and allowed to adhere at 37°C for 12 hours. Test compounds were then added to individual wells. Control cells were treated with 0.2% DMSO. After 72 hours of incubation, cells were washed with ice-cold PBS and lysed at 4°C for 30 minutes in RIPA lysis buffer (50 mM Tris-HCl, 1% v/v NP-40, 0.35% w/v sodium-deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, pH 7.4, 1 mM phenylmethylsulfonyl fluoride, 1 mM NaF, 1 mM Na3VO4) containing a protease-inhibitor cocktail (Roche, Germany). Each lysate was centrifuged at 15 000g for 30 minutes to obtain a supernatant. Then, 50 mL of the supernatant was added to 100 mL of freshly prepared substrate solution (0.1% L-dopa) in a well on a 96-well plate. Following 1 hour of incubation, optical densities were determined at 475 nm with a multimode microplate reader (BioTek Instruments, Inc, USA). Protein concentration of each lysate was determined by Bio-Rad protein assay (BIO-RAD, USA). Tyrosinase activity normalized with protein amount was shown as a percentage value. Each percentage value of the compound-treated cells was calculated with respect to that of DMSO-treated cells. Each treatment was repeated 3 times.
Measurement of Cellular Melanin
Cellular melanin content was measured as described previously with a slight modification. 24 B16 cells were seeded in 6-well plates (20 × 10 4 cells/well) and allowed to adhere at 37°C for 12 hours. After adding test samples, cells were incubated for 72 hours and then washed with PBS and lysed in 150 mL of 1M NaOH followed by 1 hour of heating at 60°C to solubilize the melanin. Each lysate (100 mL) was put in a well of a 96-well microplate, and the absorbance was measured at 475 nm with a microplate spectrophotometer (BD Bioscience, USA). Protein concentration of each sample was determined by Bio-Rad protein assay (BIO-RAD, USA). Each experiment was repeated 3 times. Intra cellular melanin amount/protein amount were shown as percentage values. Each percentage value of the compoundtreated cells was calculated with respect to that of DMSO-treated cells.
Scratch Assay
The spreading and migration capabilities of B16 cells were assessed using a scratch wound assay, which measures the expansion of a cell population on surfaces. 25, 26 Cells were seeded into 24-well plates and cultured in medium containing 10% FBS until cell monolayers were nearly confluent. A linear wound was then generated in the monolayer with a sterile 10-mL pipette tip. The cellular debris was removed by washing the plate with PBS. AT-І, AT-II, ATR, or DMSO was added and incubated for 24 hours. Scratches were photographed under a microscope (100×) immediately after the wounding procedure and once more after 24 hours of incubation. Experiments were performed at least 3 times.
Western Blot Analysis
Cells were collected and proteins were extracted with RIPA lysis buffer (50 mM Tris-Cl, 1% v/v NP-40, 0.35% w/v sodium-deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, pH 7.4, 1 mM phenylmethylsulfonyl fluoride, 1 mM NaF, 1 mM Na 3 VO 4 ) containing a protease-inhibitor cocktail (Roche, Germany). Protein concentration was determined by Bio-Rad protein assay (BIO-RAD, USA). Equal amounts of individual protein samples were separated by SDS-PAGE (polyacrylamide gel electrophoresis) and then electro transferred onto the nitrocellulose membrane (Amersham Biosciences, USA). Membranes were blocked for 30 min with 5% skim milk in TBST (Tris-buffered saline with Tween-20) buffer composed of 50 mM Tris (pH 7.6), 150 mM NaCl, and 0.1% Tween-20 and incubated with specific antibodies against p-AKT, AKT, p-ERK, or ERK (Santa Cruz, USA) overnight at 4°C. b-Actin was used as loading control and was detected using an antiactin polyclonal antibody (Santa Cruz, USA). After incubation with secondary antibodies, ECL (enhanced chemiluminescent) detection reagents (Amersham Biosciences, USA) were used to detect signals.
Statistics
Results were expressed as means ± standard deviation. Statistical analyses were performed by Student's t test. P < .05 was considered to be statistically significant.
Results
Compound Chemistry
Eight sesquiterpene compounds were isolated from LAR and were identified as AT-І, AT-II, AT-III, ATR, BIA, BIE, JUN, and EUD by nuclear magnetic resonance (NMR) and mass spectroscopy (MS) analyses. Their chemical structures are shown in Figure 1 , and 13 C NMR data are presented in Table 1 
Effects of LAR Sesquiterpenes on Melanoma B16 Cell Viability
Effects of the 8 compounds from LAR on cell viability were assessed by MTT assay in B16 cells. The inhibition of cell viability by each compound at 100 mM was expressed as percentage of the viability of the control group. AT-І, AT-II, and ATR were the most potent among the 8 compounds. AT-І, AT-II, and ATR reduced cell viability by 73.47%, 60.97%, and 82.85%, respectively (Figure 2A) . Each of the 3 compounds was further tested at different concentrations, and the IC 50 values of AT-І, AT-II, and ATR were determined to be 76.46 ± 2.20, 84.02 ± 1.79, and 54.88 ± 1.22 mM (n = 3), respectively from the doseresponse curves ( Figure 2B) with GraphPad Prism 5.0 software (GraphPad Software Inc, San Diego, CA).
Effects of AT-I, AT-II, and ATR on B16 Cell Differentiation
The differentiation status of cells was first monitored by assessing the formation of dendritelike cellular protrusions. As shown in Figure 3A , cells treated for 72 hours with AT-І, AT-II, or ATR showed typical dendritelike cellular protrusions, whereas DMSO-treated control cells showed no such phenotype, indicating that AT-І, AT-II, and ATR could effectively induce differentiation in B16 cells.
To validate the implications of these morphological observations, cellular tyrosinase activity and melanin content, whose status can mirror differentiation status of melanoma cells, 30, 31 were determined. Results showed that tyrsosinase activity ( Figure 3B ) and melanin content ( Figure 3C ) were increased in a dose-dependent manner in B16 cells treated with AT-І, AT-II, or ATR for 72 hours, further supporting the hypothesis that these compounds induce differentiation.
Effects of AT-I, AT-II, and ATR on B16 Cell Migration
We performed wound-healing migration assays to determine the effects of AT-І, AT-II, and ATR on B16 cell migration. As shown in Figure 4A , DMSO-treated B16 cells were able to invade the scratched area that is almost recolonized 24 hours later. However, AT-І, AT-II, and ATR strongly impaired this process in a dose-dependent fashion. Very few cells in the high-dose group were in the scratched area, and the distance between the borders of the wound was significantly different from that of the control group 24 hours after the scratch.
To determine whether these findings resulted from the antiproliferative effects of the tested compounds, cell viability was determined by the MTT assay. Results showed that all 3 compounds had no significant antiproliferative effect at any of the tested concentrations ( Figure 4B ).
Effects of AT-I, AT-II, and ATR on ERK and AKT activities
To investigate the signaling cascades that might be involved, we detected the activation of ERK and AKT in response to the treatment with LAR sesquiterpenes. AT-I or AT-II treatment for 48 hours resulted in an elimination of active ERK, whereas treatment of ATR had no influence on the expression of active ERK, as measured with phosphospecific antibodies ( Figure 5 ). The expression level of phosphorylated AKT was significantly reduced in B16 cells treated with each of the 3 compounds ( Figure 5 ).
Discussion
LAR has been traditionally used as a remedy for abdominal pain and gastrointestinal diseases for thousands of years in China. 1 Recent clinical studies showed that AT-I, a sesquiterpene compound from LAR, has beneficial effects in patients with gastric cancer cachexia. 17, 18 Sesquiterpene compounds from LAR also showed anticancer activities in various carcinoma cell lines. 14, 15, 32 In this study, we reported the effects of sesquiterpene compounds isolated from LAR on B16 cells for the first time.
A total of 8 sesquiterpene compounds were isolated from LAR with column chromatography. All of them could inhibit cell growth at 100 mΜ in B16 cells. AT-І, AT-II, and ATR showed the highest inhibitory effects, suggesting that monomer lactone and lactam structures are critical for the antiproliferative activities of LAR sesquiterpenes. ATR, a lactam compound showed the most potent cell-growthinhibiting effect among the 8 compounds, suggesting that the nitrogen atom in the structure plays an important role in the efficacy. Our results also indicated that AT-III has weaker potency compared with its structural analogs AT-І and AT-II. The only structural difference among the 3 compounds is that AT-III has a hydroxyl group at the C-8 position, indicating that introduction of a hydroxyl group into the structure impairs its anticancer activity. In line with our findings, AT-III has been reported to have weaker apoptotic effect compared with AT-І or AT-II on HL-60 and P-388 cells. 14, 15 Cancer is fundamentally a disease of abnormal cell differentiation 33 and can be controlled by agents with a normalizing effect on cell differentiation. 34 We observed that AT-І, AT-II, and ATR could induce B16 cells to produce dendritelike protrusions and increase cellular tyrosinase activity and melanin production, suggesting that these 3 compounds induced differentiation in B16 cells. Therefore, AT-І, AT-II, or/and ATR may provide nontoxic differentiation therapy for melanoma.
Cell migration is a highly integrated multistep process that contributes to tissue repair and regeneration and also drives disease progression in mental retardation, atherosclerosis, arthritis, and cancer. 35 In this study, we found that AT-І, AT-II, or ATR was able to effectively inhibit cell migration at concentrations that do not cause observable cytotoxicity, indicating that AT-І, AT-II, or ATR may inhibit metastasis of invasive melanoma.
In melanoma, Ras/ERK and PI3K/AKT signaling pathways are constitutively activated. 36 Both pathways have been identified as central regulators of cell proliferation, differentiation, migration, angiogenesis, and tumor development, contributing to the malignant phenotype of the tumor. 36 Inhibitors of the 2 pathways such as sorafenib and everolimus have been used in melanoma treatment. However, the outcomes are not satisfactory. 36 Because both pathways play a key role in melanoma development, parallel inhibition of targets in both pathways may result in synergistic inhibition of growth in melanomas. 37 Our results demonstrated that AT-I and AT-II could inhibit both ERK and AKT activation, suggesting that these 2 compounds are potentially effective agents for melanoma therapy. Although ATR inhibited only AKT activation, it exhibited more potent anticancer properties than AT-I and AT-II, implying that other mechanisms are involved in ATR activities. Thus, ATR appears to deserve further study for use in therapy for melanoma.
Conclusions
We have isolated 8 sesquiterpene compounds from LAR. EUD was isolated from LAR for the first time. All 8 compounds inhibited the growth of B16 cells; AT-I, AT-II, and ATR were the most potent. AT-I, AT-II, and ATR could also induce cell differentiation and inhibit cell migration through inactivating Ras/ERK MAPK (for AT-I and AT-II) and PI3/AKT (for all the 3) pathways. These findings provide a basis for further investigations of sesquiterpene compounds from LAR for treating malignant melanoma. 
